North America

Fri
08
Mar

Cannabis female executives feel frustration on International Women's Day

March 8 is International Women’s Day and while there are many successes to celebrate in the cannabis industry for women, there is increasingly the feeling that many of the early gains are slipping away. In the early days of the cannabis industry, it was estimated that over 36% of the companies were led by women, that number is believed to have slipped to 27%. Some think it is even lower.

Diane Katz, President of Electrum Partners, a venture management company specializing in
medical and adult use cannabis and ancillary businesses said, “I know many women in the space and they are extremely frustrated.” Katz noted that she has a great deal of experience in many industries and feels the cannabis industry treats women worse than other industries.

Fri
08
Mar

Cannvas and Ellementa partner to answer women’s questions about cannabis, health and wellness

Cannvas MedTech Inc. and Ellementa, Inc. have teamed up to better serve women across North America who are interested in the potential health benefits of cannabis.

“With 35 percent of women consumers using cannabis for medical reasons, Cannvas.Me data shows health and wellness issues are primary reasons why women explore cannabis as an alternative treatment,” notes a statement from Cannvas, a digital cannabis education and analytics company that seeks to deliver deeper insights into consumer behaviour and cannabis consumption across Canada.

Fri
08
Mar

The prohibition of cannabis is sexist. And it has been for a long time

Female cannabis plants are the ones worth money — the ones that yield medicine, writes Tess Barker. Perhaps it should come as no surprise, then, that cannabis and women have long and entangled roots. According to Dr. Ethan Russo, in his 2002 paper 'Cannabis Treatments in Obstetrics and Gynecology: A Historical Review,' known instances of women using cannabis medicinally date back to Ancient Mesopotamia. In ancient Judea, the plant was used in childbirth. Doctors in 16th century China prescribed it for menstrual disorders.

Fri
08
Mar

OPINION: Considering cannabis and women’s health on International Women’s Day 2019

Legalization of recreational cannabis in Canada is now centre stage, setting the spotlight on adult use, but also upping the profile of its elder predecessor: medical cannabis.

Fri
08
Mar

Meet the 2019 High Times Women of Weed honorees

High Times strives to uplift and center the women who make the cannabis space what it is: innovative, progressive, inclusive, and welcoming. This International Women’s Day, we’d like to announce the 2019 High Times Women of Weed honorees. These twenty individuals have made significant change, progress, and advances in their fields—and of course, in cannabis. Ahead of this year’s Women of Weed event, here are the honorees and what they do:

Fri
08
Mar

3 Marijuana Stocks That Beat Aurora Cannabis to Profitability

Over the past year, a number of marijuana milestones and trends have taken hold. We've seen Canada legalize recreational marijuana, pot players move into the hemp and cannabidiol space, and more recently witnessed a push by publicly listed pot stocks to uplist from the over-the-counter exchange to reputable U.S. exchanges, like the New York Stock Exchange (NYSE) and Nasdaq.

This last trend, uplisting, might not seem like a big deal, but it's been crucial in increasing the visibility, validity, and access to equity for the legal cannabis industry. It's also encouraging Wall Street firms to initiate coverage of marijuana stocks.

Fri
08
Mar

THC-A: A better anti-inflammatory and neuro-protectant

While there has been a lot of discussion in the literature, both lay and scientific, about the properties of Cannabidiol (CBD) as an anti-inflammatory and neuroprotectant, there are significant problems with CBD in reality. Tetrahydrocannabinolic acid (THC-A) is another cannabinoid (cannabis-derived medication) that has yet to get the attention it truly deserves. THC-A presents an option that is similar to CBD but better!

Aside from what CBD appears to be able to treat, its main attraction is that it is non-intoxicating (meaning it doesn’t get you high). On the downside, however, the amount of CBD you need to take to get the benefits described in medical studies is 500-1500mg per day, or about $30-80 per day. This is pretty much a show stopper for most patients.

Fri
08
Mar

CO2 v. ethanol extraction: What’s the difference?

Oils, topicals, vapes, pills and edibles: As the market literally blossoms with alternatives to the standard joint and lighter, cannabis extracts are looking pretty sleek.

Colloquially referred to as “hash” or “kief”, depending on the context, producers and consumers alike have been known to employ expensive equipment and don safety gear to suss out cannabis’ raw potential as both a pain-easing healer and a perception-twisting stimulant.

However, precisely how cannabis extract makes its way from the dense, sticky leaves of its native plant to brownies, tinctures and creams hinges on what extraction specialists want out of it.

Fri
08
Mar

How companies can prepare for doing business in the hemp age

Researchers, manufacturers and retailers nationwide are crossing their fingers anticipating a fully-legalized future for marijuana and hemp-based products. Since Senate Majority Leader Mitch McConnell introduced a small amendment to the 2018 Farm Bill that lifted the federal ban on hemp cultivation, hemp-derived products are now poised to spread throughout the country. 

Like it or not, the legal marijuana industry has arrived — and it’s likely to keep growing (pun intended). Companies everywhere, from banks and retailers to professional services and marketing agencies, must decide how they’ll work with these burgeoning businesses. 

Fri
08
Mar

4 marijuana stocks with superior crop yields

The past six months have been an absolute whirlwind for the marijuana industry. In October, we witnessed the industry gain the legitimacy it's sought for so long after Canada became the first industrialized country in the world to legalize recreational cannabis. Then, just weeks later, the U.S. midterm elections increased the number of states to have given the green light to medical cannabis to 33. A month later, President Trump signed the Farm Bill into law, legalizing hemp and hemp-derived cannabidiol products. At seemingly every turn, the outlook for the cannabis industry has been improving.

Pages

Subscribe to RSS - North America